SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-22-000010
Filing Date
2022-08-09
Accepted
2022-08-09 09:01:35
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20220630.htm   iXBRL 10-Q 1389901
2 EX-31.1 exhibit311q22022.htm EX-31.1 10955
3 EX-31.2 exhibit312q22022.htm EX-31.2 10775
4 EX-32.1 exhibit321q22022.htm EX-32.1 5533
5 EX-32.2 exhibit322q22022.htm EX-32.2 5348
  Complete submission text file 0001012477-22-000010.txt   5668678

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20220630.xsd EX-101.SCH 33484
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20220630_cal.xml EX-101.CAL 69006
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20220630_def.xml EX-101.DEF 138179
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20220630_lab.xml EX-101.LAB 411682
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20220630_pre.xml EX-101.PRE 268006
59 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20220630_htm.xml XML 967129
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 221146812
SIC: 2834 Pharmaceutical Preparations